#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 62

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Binge eating

Not recruiting

Investigational

Study on BP1.4979 for Treating Binge Eating Disorder in Women with Moderate to Severe Symptoms

Investigational

France

Participants:18–64 years · 65+ years
Substances:N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Bevacizumab, Atezolizumab, and RO7247669 in Patients with Resectable Liver Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Pancreatic carcinoma+3

Not recruiting

InvestigationalNo placebo

Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:(3S,3'S,3A's,10A's)-6-Chloro-3'-(3-Chloro-2-Fluorophenyl)-1'-(Cyclopropylmethyl)-6'-Methyl-2-Oxo-1,2,3',3A',10',10A'-Hexahydro-1'H-Spiro[Indole-3,2'-Pyrrolo[2',3':4,5]Pyrrolo[1,2-B]Indazole]-7'-Carboxylic Acid

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Doxorubicin

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on Izokibep for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

France

Participants:18–64 years · 65+ years
Substances:Izokibep

Contact Research Centre

Diffuse large B-cell lymphoma+2

Not recruiting

Registered drugNo placebo

Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Adenocarcinoma gastric

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Crizotinib

Contact Research Centre

Chronic hepatitis B+1

Not recruiting

Investigational

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational

France

Participants:18–64 years · 65+ years
Substances:Bepirovirsen

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.